Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania

AIDS Patient Care and STDs

Volumn 25, Issue 10, 2011, Pages 579-585

  Mehta, Saurabh ^a   Mugusi, Ferdinand M ^b   Spiegelman, Donna ^c   Villamor, Eduardo ^c,d   Finkelstein, Julia L ^a   Hertzmark, Ellen ^c   Giovannucci, Edward L ^c,e   Msamanga, Gernard I ^b   Fawzi, Wafaie W ^c  

^a Department of Obstetrics Gynecology   (United States)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA TOCOPHEROL; ANTIRETROVIRUS AGENT; ASCORBIC ACID; CHLOROQUINE; FOLIC ACID; IRON; MULTIVITAMIN; PLACEBO; RETINOL; VITAMIN B COMPLEX; VITAMIN D;

ACUTE UPPER RESPIRATORY TRACT INFECTION; ADULT; ANTIVIRAL THERAPY; ARTICLE; BODY MASS; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DYSENTERY; FATIGUE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALARIA; MORBIDITY; MOUTH PAIN; NAUSEA AND VOMITING; ODYNOPHAGIA; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; PREGNANT WOMAN; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RASH; RISK FACTOR; TANZANIA; THRUSH; TONGUE PAIN; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WASTING SYNDROME; WEIGHT REDUCTION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CANDIDIASIS, ORAL; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HIV INFECTIONS; HIV WASTING SYNDROME; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PROPORTIONAL HAZARDS MODELS; RESPIRATORY TRACT INFECTIONS; TANZANIA; TREATMENT OUTCOME; VITAMIN D; VITAMINS; YOUNG ADULT;

EID: 80053411195     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2011.0182     Document Type: Article

References (53)

1. Adams JS, Liu PT, Chun R, Modlin RL, Hewison M. Vitamin D in defense of the human immune response. Ann NY Acad Sci 2007;1117:94-105. (Pubitemid 350191275)
2. deLuca HF. Metabolism and molecular mechanism of action of vitamin D: 1981. Biochem Soc Trans 1982;10:147-158.
3. Stroder J. Immunity In Vitamin D Deficient Rickets. Vitamin D And Problems Of Uremic Bone Disease. Berlin: de Gruyter; 1975:675-687.
4. Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: Vvitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007;179:2060-2063.
5. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311:1770-1773.
6. Bischoff-Ferrari HA. Vitamin D and fracture prevention. Endocrinol Metab Clin North Am 2010;39:347-353, table of contents.
7. Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, Hathcock J, Giovannucci E, Willett WC. Benefit-risk assessment of vitamin D supplementation. Osteoporos Int 2010;21:1121-1132.
8. Souberbielle JC, Body JJ, Lappe JM, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev 2010;9:709-715.
9. Wang L, Manson JE, Song Y, Sesso HD. Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010;152:315-323.
10. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: A negative endocrine regulator of the reninangiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004;89-90:387-392. (Pubitemid 38844316)
11. Parker J, Hashmi O, Dutton D, et al. Levels of vitamin D and cardiometabolic disorders: Systematic review and metaanalysis. Maturitas 2010;65:225-236.
12. Fawzi WW, Msamanga GI, Spiegelman D, et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med 2004;351:23-32. (Pubitemid 38857244)
13. Mehta S, Giovannucci E, Mugusi FM, et al. Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS ONE 2010;5:e8770.
14. Fawzi WW, Msamanga GI, Spiegelman D, Urassa EJ, Hunter DJ. Rationale and design of the Tanzania Vitamin and HIV Infection Trial. Control Clin Trials 1999;20:75-90. (Pubitemid 29074370)
15. WHO. Proposed 'World Health Organization staging system for HIV infection and disease': Preliminary testing by aninternational collaborative cross-sectional study. The WHO International Collaborating Group for the Study of the WHO Staging System. AIDS 1993;7:711-718.
16. Urassa W, Matunda S, Bredberg-Raden U, Mhalu F, Biberfeld G. Evaluation of the WHO human immunodeficiency virus (HIV) antibody testing strategy for the diagnosis of HIV infection. Clin Diagn Virol 1994;2:1-6. (Pubitemid 24091441)
17. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005;135:317-322. (Pubitemid 40194499)
18. Bodnar LM, Simhan HN, Powers RW, Frank MP, Cooperstein E, Roberts JM. High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr 2007;137: 447-452. (Pubitemid 46213463)
19. Villamor E, Saathoff E, Manji K, Msamanga G, Hunter DJ, Fawzi WW. Vitamin supplements, socioeconomic status, and morbidity events as predictors of wasting in HIVinfected women from Tanzania. Am J Clin Nutr 2005;82: 857-865. (Pubitemid 43779701)
20. van der Sande MA, Schim van der Loeff MF, Aveika AA, et al. Body mass index at time of HIV diagnosis: A strong and independent predictor of survival. J Acquir Immune Defic Syndr 2004;37:1288-1294. (Pubitemid 39281511)
21. James WP, Mascie-Taylor GC, Norgan NG, Bistrian BR, Shetty PS, Ferro-Luzzi A. The value of arm circumference measurements in assessing chronic energy deficiency in Third World adults. Eur J Clin Nutr 1994;48:883-894.
22. Wanke C, Kotler D. Collaborative recommendations: The approach to diagnosis and treatment of HIV wasting. J Acquir Immune Defic Syndr 2004;37:S284-S288. (Pubitemid 39602331)
23. Polsky B, Kotler D, Steinhart C. HIV-associated wasting in the HAART era: Guidelines for assessment, diagnosis, and treatment. AIDS Patient Care STDs 2001;15:411-423. (Pubitemid 32762700)
24. Cox D. Regression models and life tables. J R Stat Soc 1972;34:187-220.
25. Govindarajulu US, Spiegelman D, Thurston SW, Ganguli B, Eisen EA. Comparing smoothing techniques in Cox models for exposure-response relationships. Stat Med 2007;26: 3735-3752. (Pubitemid 47307746)
26. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989;8:551-561. (Pubitemid 19116001)
27. Diggle P, Liang KY, Zeger SL, eds. Analysis of Longitudinal Data. Oxford, England: Oxford University Press, 1995.
28. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989;79:340-349. (Pubitemid 19077878)
29. Miettinen O. Theoretical Epidemiology. Vol 107. New York: John Wiley & Sons, 1985.
30. Mueller NJ, Fux CA, Ledergerber B, et al. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS 2010;24:1127-1134.
31. Bang UC, Shakar SA, Hitz MF, et al. Deficiency of 25- hydroxyvitamin D in male HIV-positive patients: A descriptive cross-sectional study. Scand J Infect Dis 2010;42:306-310.
32. Overton ET, Yin MT. The rapidly evolving research on vitamin D among HIV-infected populations. Curr Infect Dis Rep 2011;13:83-93.
33. Wasserman P, Rubin DS. Highly prevalent vitamin D deficiency and insufficiency in an urban cohort of HIV-infected men under care. AIDS Patient Care STDs 2010;24:223-227.
34. Dao CN, Patel P, Overton ET, et al. Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis 2011;52:396-405.
35. Stein EM, Yin MT, McMahon DJ, et al. Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African- American women. Osteoporos Int 2011;22:477-487.
36. Adeyemi OM, Agniel D, French AL, et al. Vitamin D deficiency in HIV-infected and un-infected women in the US. J Acquir Immune Defic Syndr (in press).
37. Finkelstein JL, Mugusi FM, Mehta S, Fawzi WW. HIV/AIDS and nutrition in the era of antiretroviral therapy: Programmatic implications for care and treatment. In: Marlink RG, Teitelman SJ, eds. From the Ground Up: Building Comprehensive HIV/AIDS Care Programs in Resource-Limited Settings. Washington, D.C.: Elizabeth Glaser Pediatric AIDS Foundation, 2009;2:193-229.
38. Palenicek JP, Graham NM, He YD, et al. Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:366-373.
39. Hsu JW, Pencharz PB, Macallan DC, Tomkins A. Macronutrients and HIV/AIDS: a review of current evidence. Durban, South Africa: World Health Organization, April 10-13, 2005.
40. Guenter P, Muurahainen N, Simons G, et al. Relationships among nutritional status, disease progression, and survival in HIV infection. J Acquir Immune Defic Syndr 1993;6:1130-1138. (Pubitemid 23293247)
41. Chlebowski RT, Grosvenor MB, Bernhard NH, Morales LS, Bulcavage LM. Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS. Am J Gastroenterol 1989;84:1288-1293. (Pubitemid 19264722)
42. Rimaniol AC, Zylberberg H, Zavala F, Viard JP. Inflammatory cytokines and inhibitors in HIV infection: Correlation between interleukin-1 receptor antagonist and weight loss. AIDS 1996;10:1349-1356. (Pubitemid 26333932)
43. Godfried MH, van der Poll T, Jansen J, et al. Soluble receptors for tumour necrosis factor: A putative marker of disease progression in HIV infection. AIDS 1993;7:33-36. (Pubitemid 23069029)
44. Acharyya S, Ladner KJ, Nelsen LL, et al. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 2004;114:370-378. (Pubitemid 39071609)
45. Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986;234:470-474. (Pubitemid 17181429)
46. Zhang Z, Yuan W, Sun L, et al. 1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells. Kidney Int 2007; 72:193-201. (Pubitemid 47067389)
47. Teegarden D, Donkin SS. Vitamin D: Emerging new roles in insulin sensitivity. Nutr Res Rev 2009;22:82-92.
48. Sun J, Kong J, Duan Y, et al. Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab 2006;291:E315-322. (Pubitemid 44035291)
49. Laverny G, Penna G, Vetrano S, et al. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease. Immunol Lett 2010;131: 49-58.
50. Cohen-Lahav M, Shany S, Tobvin D, Chaimovitz C, Douvdevani A. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels. Nephrol Dial Transplant 2006;21:889-897.
51. Cohen-Lahav M, Douvdevani A, Chaimovitz C, Shany S. The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages. J Steroid Biochem Mol Biol 2007;103: 558-562.
52. Adams LS, Teegarden D. 1,25-dihydroxycholecalciferol inhibits apoptosis in C3H10T1/2 murine fibroblast cells through activation of nuclear factor kappaB. J Nutr 2004; 134:2948-2952. (Pubitemid 39470067)
53. Spector SA. Vitamin D earns more than a passing grade. J Infect Dis 2009;200:1015-1017.